The Community Engagement and Outreach (CEO) Core of the West Virginia Clinical and Translational Science Institute (WVCTSI) brings patients, providers, and community members together to ensure that the Institute's research agenda reflects the health priorities of rural communities, and that study findings and recommendations inform practical, sustainable, and scalable strategies to promote health. CEO's efforts are informed by a state- wide Community Advisory Board representing lay communities, patients, health care providers, public health workers, civic organizations, payers, and philanthropic non-profits organizations. The overall goal of CEO is to ensure that all West Virginians benefit from the advances in biomedical and behavioral approaches that will ultimately improve our state's health outcomes with realization of the following specific aims: 1) actively engage patients and other community stakeholders as research partners, 2) transform community-identified research questions into externally-funded projects that improve health outcomes in WVCTSI priority health areas, including addiction & emerging epidemics (e.g., hepatitis C), cancer, cardiovascular disease, and chronic lung disease, and 3) translate and disseminate research results to inform West Virginia health policy and practice. We will accomplish these Aims through a community-based research and education process to build trust and enhance learning. This process will include completing community concept maps and creating and implementing a novel curriculum on community-based participatory research for use with rural populations.
Aim 1 achievement will result in engaged patients and community members who are motivated to serve as research partners but who will need assistance to do so. Similarly, many investigators and health care providers are inexperienced in community-engaged research and will also need guidance.
For Aim 2, CEO will employ shared learning approaches for training, mentoring, and technical assistance in community-engaged research approaches. Our diverse partners will learn from each other, combining their capacities in a complementary fashion to conduct research with translational impact, affording a level of understanding and trust that could not be achieved by individually engaging stakeholders.
Aim 3 activities include working with patient, provider, community members, and research partners to develop a comprehensive dissemination plan, providing translation and distribution of research results to multiple audiences. Dissemination of findings back to our partners to inform health policy and practice brings us full circle in our engagement efforts.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54GM104942-02
Application #
9362161
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
West Virginia University
Department
Type
DUNS #
191510239
City
Morgantown
State
WV
Country
United States
Zip Code
26506
Ren, Xuefang; Engler-Chiurazzi, Elizabeth B; Russell, Ashley E et al. (2018) MiR-34a and stroke: Assessment of non-modifiable biological risk factors in cerebral ischemia. Neurochem Int :
Hodder, Sally; Squires, Kathleen; Kityo, Cissy et al. (2018) Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed Women. J Acquir Immune Defic Syndr 78:209-213
Paquette, Catherine E; Pollini, Robin A (2018) Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review. Drug Alcohol Depend 188:239-250
Kristjansson, Alfgeir L; Kogan, Steven M; Mann, Michael J et al. (2018) Does early exposure to caffeine promote smoking and alcohol use behavior? A prospective analysis of middle school students. Addiction :
Khouj, Yasser; Dawson, Jeremy; Coad, James et al. (2018) Hyperspectral Imaging and K-Means Classification for Histologic Evaluation of Ductal Carcinoma In Situ. Front Oncol 8:17
Tok, Fatih; Kocyigit-Kaymakcioglu, Bedia; Tabanca, Nurhayat et al. (2018) Synthesis and structure-activity relationships of carbohydrazides and 1,3,4-oxadiazole derivatives bearing an imidazolidine moiety against the yellow fever and dengue vector, Aedes aegypti. Pest Manag Sci 74:413-421
Rich, Katherine M; Bia, Joshua; Altice, Frederick L et al. (2018) Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? Curr HIV/AIDS Rep 15:266-275
King, Dana E; Xiang, Jun; Pilkerton, Courtney S (2018) Multimorbidity Trends in United States Adults, 1988-2014. J Am Board Fam Med 31:503-513
Kapadia, Shashi N; Grant, Robert R; German, Susan B et al. (2018) HIV virologic response better with single-tablet once daily regimens compared to multiple-tablet daily regimens. SAGE Open Med 6:2050312118816919
Wiener, R Constance; Shen, Chan; Findley, Patricia et al. (2018) Dental Fluorosis over Time: A comparison of National Health and Nutrition Examination Survey data from 2001-2002 and 2011-2012. J Dent Hyg 92:23-29

Showing the most recent 10 out of 998 publications